Therefore, we initiated this study to analyze the protein expression of ACE2, TMPRSS2, and FURIN on a panel of NSCLC patient tissue samples, taking into account neo-adjuvant therapies. This evidence concerns the gene ACE2 and non-small cell lung carcinoma.